Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 223

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 223
---
 their terms, be exercised at any time within the three-month
period after the date of such retirement (or such different period as the Administrator shall prescribe).

Notwithstanding any of the
foregoing, if a grantee’s employment or services with us or any of our affiliates is terminated for “cause” (as defined
in the 2021 Plan), all outstanding awards held by such grantee (whether vested or unvested) will terminate on the date of such termination
and the shares covered by such awards shall again be available for issuance under the 2021 Plan.

Voting Rights. Except
with respect to restricted share awards, grantees will not have the same rights as a shareholder with respect to any of our shares covered
by an award until the award has vested and/or the grantee has exercised such award, paid any exercise price for such award and becomes
the record holder of the shares. With respect to restricted share awards, grantees will possess all incidents of ownership of the restricted
shares, including the right to vote and receive dividends on such shares.

Dividends. Grantees
holding restricted share awards will be entitled to receive dividends and other distributions with respect to the shares underlying the
restricted share award. Any share split, share dividend, combination of shares or similar transaction will be subject to the restrictions
of the original restricted share award. Grantees holding RSUs will not be eligible to receive dividend but may be eligible to receive
dividend equivalents.

Transactions. In the
event of a share split, reverse share split, share dividend, recapitalization, combination or reclassification of our shares, the Administrator
in its sole discretion may, without the need for a consent of any holder of an award, make an appropriate adjustment in order to adjust
(i) the number and class of shares reserved and available for grants of awards, (ii) the number and class of shares covered by outstanding
awards, (iii) the exercise price per share covered by any award, (iv) the terms and conditions concerning vesting and exercisability and
the term and duration of the outstanding awards, (v) the type or class of security, asset or right underlying the award (which need not
be only that of ours, and may be that of the surviving corporation or any affiliate thereof or such other entity party to any of the above
transactions), and (vi) any other terms of the award that in the opinion of the Administrator should be adjusted; provided that any fractional